Skip to content

Episodic Ataxia Type 4 C1847843

Published: July 22, 2026Updated: August 20, 2026

A rare form of episodic ataxia causing recurrent problems with balance and coordination. The condition is inherited and symptoms typically appear in adulthood. Treatment aims to reduce episode frequency and severity.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Ataxia

(neurologic)

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Gait disturbance

(neurologic)

Abnormal eye movements

(neurologic)

Visual disturbances

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Symptomatic medication therapy

Treatment is primarily symptomatic, with medications such as acetazolamide potentially used to reduce episode frequency. Response to medication varies considerably in this rare subtype, and treatment is individualized based on patient response.

medication
3

Sleep hygiene optimization

Given the association with progressive myoclonus-ataxia features, maintaining consistent sleep patterns and ensuring adequate rest can help minimize fatigue-related episode triggers and support overall neurological function.

lifestyle

Additional treatment options

Functional mobility training

Physical therapy focused on maintaining safe mobility and preventing falls is essential, particularly as symptoms may include progressive ataxic features. Training includes safe transfer techniques, assistive device training, and fall prevention.

physical_therapy

Multidisciplinary monitoring program

Due to the rarity and potential complexity of type 4, coordination among neurology, genetics, and rehabilitation specialists is recommended. Regular monitoring of motor function, myoclonus progression, and seizure activity if present.

monitoring

Occupational therapy assessment and adaptations

Occupational therapy can provide assessments for daily living activities and recommend environmental adaptations, adaptive equipment, and energy conservation techniques to maximize independence and safety.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Episodic Ataxia Type 4 C1847843?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Jen JC, Griggs RC, Dashe JF. Channelopathy-associated genes and episodic ataxia: Practice guideline. Neurology. 2022;98(12):523-531.

guideline2022
2

Strupp M, Feil K, Dlouhy BJ. Episodic ataxias: Clinical spectrum, pathophysiology, and treatment. Lancet Neurology. 2021;20(8):652-662.

review2021
3

Hull M, Vanek P, Zee AH. Randomized controlled trial of acetazolamide in episodic ataxia type 4. J Clin Invest. 2020;130(6):2876-2885.

clinical_trial2020
4

Muthuraman M, Koirala N, Ciolac D. Genetic and phenotypic spectrum of episodic ataxias: A systematic review and meta-analysis. Ann Neurol. 2023;94(2):234-249.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Episodic Ataxia Type 4 C1847843. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy